Ravizzini, PI, Shulsinger, D, Guarnizo, E, Pavlovich, CP, and Sosa, RE: Hand-assisted laparoscopic donor nephrectomy versus standard laparoscopic donor nephrectomy:A comparitve study in a canine model. Tech in Urology 5:174-178, 1999

Guarnizo, E, Pavlovich, CP, Seiba, M, Carlson, D, Vaughan, ED and Sosa, RE: Ureteroscopic biopsy of upper tract urothelial carcinoma: Imporved accuracy and histopathologic considerations using a multi-biopsy approach. J Urol 163:52-55, 2000

Stifelman, M, Sosa, RE, Andrade, A and Shichman S: Hand-assisted Laparoscopic Nephroureterectomy. Accepted for Publication Urology

Bander NH: Comparison of antigen expression of human renal cancer in vivo and in vitro. Cancer 1984; 53:1235-1239.

Cordon-Cardo C, Bander NH, Fradet Y, Finstad CL, Whitmore WF Jr, Lloyd KO, Oettgen HF, Melamed MR and Old LJ: Immunoanatomic dissection of the human urinary tract by monoclonal antibodies. J Histochem Cytochem 1984; 32:1035-1040.

Bander NH, Welt S, Houghton AN, Lloyd KO, Grando R, Yeh S, Whitmore WF Jr, Vaughan ED Jr, Oettgen HF and Old LJ: Radionuclide imaging of human renal cancer with labeled monoclonal antibodies. Surg Forum 1984; 35:652-655.

Bander NH: Renal cancer: A model system for the study of human neoplasia. In: Contributions in Oncology, Riethmuller G, Koprowski H, von Kleist S, eds. (S. Karger, Basel) 1984.

Finstad CL, Cordon-Cardo C, Bander NH, Whitmore WF Jr, Melamed MR and Old LJ: Specificity analysis of mouse monoclonal antibodies defining cell surface antigens of human renal cancer. Proc Natl Acad Sci USA 1985; 82:2955-2959.

Bander NH, Cordon-Cardo C, Finstad CL, Whitmore WF Jr, Vaughan ED Jr, Oettgen HF, Melamed MR and Old, LJ: Immunohistologic dissection of the human kidney using monoclonal antibodies. J Urol 1985; 133:502-505.

Bander NH: Study of the normal human kidney and kidney cancer with monoclonal antibodies. Uremia Invest 1985; 8:263-273.

Fleischmann J, Heston W, Bauer W, Ratliff T, Bander NH and Fair W: Human renal cell carcinoma xenograft morphology, growth and chemosensitivities. J Urol 1985; 134:570-574.

10. Bander NH and Cordon-Cardo C: Monoclonal antibody defined markers of human renal cancer. In: Monoclonal Antibodies to Tumor Markers, Sell S, Reisfeld R, eds.(Humana Press, Clifton, NJ), 1985.

Cordon-Cardo C, Lloyd KO, Finstad CL, McGroarty ME, Reuter VE, Bander NH, Old LJ and Melamed MR: Immunoanatomic distribution of blood group antigens in the human urinary tract. Influence of secretor status. Lab Invest 1986; 55:444-454.

Tolkoff-Rubin NE, Cosimi AB, Delmonico FL, Russell PS, Thompson RE, Piper DJ, Hansen WP, Bander NH, Finstad CL, Cordon-Cardo C, Klotz LH, Old LJ and Rubin RH: Monitoring of renal proximal tubular injury in transplantation with a monoclonal antibody-based assay for the adenosine deaminase-binding protein. Transplant Proc 1986; 18:716-718.

Bander NH: Monoclonal antibodies. In: American Urological Association Update, Ball TP Jr, Novick DE, eds. (AUA Office of Education, Houston, TX) 1986.

Bander NH: Monoclonal antibodies and the diagnosis and treatment of bladder cancer. In: Bladder Cancer: Future Directions for Treatment, Yagoda A, ed. (John Wiley & Sons, NY, NY) 1986.

Bander NH and Klotz LH: Tumor immunology: In: Urologic Oncology, Graham S Jr, ed. (Raven Press, NY, NY) 1986.

Cordon-Cardo C, Finstad CL, Bander NH, Old LJ and Melamed MR: Immunoanatomic distribution of cytostructural and tissue-associated antigens in the human urinary tract. Am J Pathol 1987; 126:269-284.

Kantor RRS, Bander NH, Finstad CL, Graf LH Jr, Lloyd KO, Old LJ and Albino AP: DNA-mediated gene transfer of a human cell surface 170-kilodalton glycoprotein. Evidence for association with an endogenous murine protein. J Biol Chem 1987; 262:15166-15171.

Bander NH: Monoclonal antibodies: State of the art. J Urol 1987; 137:603-612.

Klotz LH and Bander NH: Monoclonal antibodies and urologic oncology: Antigenic expression on genitourinary tumors. In: Genitourinary Cancer, Ratliff TL, Catalona WJ, eds. (Martinus Nijhoff Publishers, Boston, MA) 1987.

Bander NH, Finstad CL, Cordon-Cardo C, Ramsawak RD, Vaughan ED Jr, Whitmore WF Jr, Oettgen HF, Melamed MR and Old LJ: Analysis of a mouse monoclonal antibody that reacts with a specific region of the human proximal tubule and subsets of renal cell carcinomas. Cancer Res 1989; 49:6774-6780.

Nanus DM, Ebrahaim SAD, Bander NH, Real FX, Pfeffer LM, Shapiro JR and Albino AP: Transformation of human kidney proximal tubule cells by ras-containing retroviruses. Implications for tumor progression. J Exp Med 1989; 169:953-972.

Wang JCL, Walle A, Novogrodsky A, Suthanthiran M, Silver RT, Bander NH, Rubin AL and Stenzel KH: A phase II clinical trial of adoptive immunotherapy for advanced renal cell carcinoma using mitogen-activated autologous leukocytes and continuous infusion of interleukin-2. J Clin Oncol 1989; 7:1885-1891.

Bander NH: ed. Renal cell carcinoma. In: Seminars in Urology, vol 7, nos 3 and 4(WB Saunders, Philadelphia, PA), 1989.

Ebert T and Bander NH: Kidney-derived cell lines. Seminars in Urology 1989; 7:247-251.

Bander NH: Monoclonal antibodies to renal cancer antigens. Seminars in Urology 1989; 7:264-270.

Nanus DM, Mentle IR, Motzer RJ, Bander NH and Albino AP: Infrequent ras oncogene point mutations in renal cell carcinoma. J Urol 1990; 143:175-178.

Nanus DM, Pfeffer LM, Bander NH, Bahri S and Albino AP: Anti-proliferative and anti-tumor effect of alpha-interferon in renal carcinoma: correlation to the expression of kidney associated differentiation glycoprotein. Cancer Res 1990; 50:4190-4194.

Ebert T, Bander NH, Finstad CL, Ramsawak RD and Old LJ: Establishment and characterization of renal cancer and normal kidney cell lines. Cancer Res 1990; 50:5531-5536.

Rettig WJ, Triche TJ and Bander NH: Somatic cell genetic analysis of human cell surface antigens 5.1H11 and F35/9 (gp45). Genomics 1990; 6:178-183.

Libby DM, Bander NH, Altorki NK, Gold J, Pitts WR Jr and Frankel SS: Simultaneous pulmonary and renal malignancy. Chest 1990; 98:153-156.

Kerr L, Huntcoon C, Donohue J, Leibson PJ, Bander NH, Ghose T, Luner SJ, Vessella R and McKean DJ: Heteroconjugate antibody-directed killing of autologous human renal carcinoma cells in in vitro activated lymphocytes. J Immunol1990; 44:4060-4067.

Bander NH: Monoclonal antibodies to renal cancer antigens. Eur Urol 1990; 18:10-12.

Ebert T and Bander NH: Immunodiagnosis of renal cancer. In: Immunodiagnosis of Cancer, Mercer DW, Herberman RB, eds. (Marcel Dekker, New York, NY) 1990; pp. 469-484.

Gastl G, Finstad CL, Guarini A, Bosl G, Gilboa E, Bander NH and Gansbacher B: Retroviral vector-mediated lymphokine gene transfer into human renal cancer cells. Cancer Res 1992; 52:6229-6236.

Bander NH, Gastl G, Nanus DM, Pfeffer LM, Finstad CL and Albino AP: Anti-proliferative and anti-tumor effect of a-interferon in renal cell carcinoma: Correlation with the expression of a kidney associated differentiation glycoprotein. In: Basic and Clinical Research on Renal Cell Carcinoma, Staehler G, Pomer S, eds. (Springer-Verlag, Heidelberg, Germany) 1992; pp. 115-120.

Oosterwijk E, Bander NH, Divgi CR, Welt S, Wakka JC, Finn R, Carswell EA, Larson SM, Warnaar SO, Fleuren GJ, Oettgen HF and Old LJ: Antibody localization in human renal cell carcinoma: A phase I study of monoclonal antibody G250. J Clin Oncol 1993; 11:738-750.

Gastl G, Abrams JS, Nanus DM, Oosterkamp R, Silver J, Liu F, Chen N, Albino AP and Bander NH: Interleukin-10 production by human carcinoma cell lines and its relationship to interleukin-6 expression. Int J Cancer 1993; 55:96-101.

Nanus DM, Engelstein D, Gastl GA, Gluck L, Vidal MJ, Morrison M, Finstad CL, Bander NH and Albino AP: Molecular cloning of the human kidney differentiation antigen gp160: human aminopeptidase A. Proc Natl Acad Sci USA 1993; 90:7069-7073.

Holt EH, Vasavada RC, Bander NH, Broadus AE and Philbrick WM: Region-specific methylation of the parathyroid hormone-related peptide gene determines its expression in human renal carcinoma cell lines. J Biol Chem 1993; 268:20639-20645.

Gnarra JR, Tory K, Weng Y, Schmidt L, Wei MH, Li H, Latif F, Liu S, Chen F, Duh F-M, Lubensky I, Duan D-S R, Florence C, Pozzatti R, Walther MM, Bander NH et al.: VHL tumor suppressor gene mutations in renal cell carcinoma tumorigenesis. Nature Genet 1994; 7:85-90.

Berger MF, Oosterwijk E, Bander NH, Divgi CR, Welt S, Wakka JC, Finn RD, Carswell EA, Larson SM, Warnaar SO, van Fleuren G, Oettgen HF and Old LJ: Antibody localization in human renal cell carcinoma: A phase I study of monoclonal antibody G250. In: Biology of Renal Cell Carcinoma, Bukowski RM, Finke JH, Klein EA, eds. (Springer-Verlag, New York, NY) 1995; pp. 257-267.

Bander NH: Immunology of renal cancer. In: Comprehensive Textbook of Genitourinary Oncology, Vogelzang NJ, Scardino PT, Shipley WU, Coffey DS, eds. (Williams & Wilkins, Philadelphia, PA) 1995; pp. 171-178.

Kinouchi T, Bander NH and Kotake T: Reactivities of mouse monoclonal antibody K2.7 to renal cancers in complement-dependent cytotoxicity and antibody dependent cell-mediated cytotoxicity. J Urol 1995; 154:288-292.

Gastl G, Ebert T, Finstad CL, Sheinfeld J, Gomahr A, Aulitzky W and Bander NH: MHC Class I and Class II expression in renal cell carcinoma and modulation by interferon-gamma. J Urol 1996; 155:361-367.

Motzer RJ, Bander NH and Nanus DM: Renal cell carcinoma. N Engl J Med 1996; 335:865-875.

Shemtov MM and Bander NH: Immunologic approaches to genitourinary malignancies. In Campbell's Urology Update (Patrick C Walsh, Alan B Retik, Thomas A Stamey, E Darracott Vaughan and Alan J Wein, eds.) Philadelphia, PA. 20:1-11, 1996.

McKiernan JM, Buttyan R, Bander NH, Stifelman MD, Katz AE, Chen M-W, Olsson CA and Sawczuk IS: Expression of the tumor-associated gene MN; a potential biomarker for human renal cell carcinoma. Cancer Res 1997; 57:2362-2365.

Oosterwijk E, Bander NH, Divgi CR, Welt S, Wakka JC, Finn RD, Carswell EA, Larson SM, Warnaar SO, Fleuren GJ, Oettgen HF, and Old LJ: Antibody localization in human renal cell carcinoma: A phase I study of monoclonal antibody G250. Classic Papers and Current Comments 1997; 2:331-344.

Nanus DM, BogenriederT, Papandreou CN, Finstad CL, Lee A, Vlamis V, Motzer RJ, Bander NH, Albino AP, and Reuter VE: Aminopeptidase A expression and enzymatic activity in primary human renal cancers. J Oncology 1998; 13(2):261-267.

Divgi C.R., Bander N.H., Scott A.M., O'Donoghue, Sgouros G, Welt S., Finn R.D., Morrissey F., Capitelli P., Williams J.M., Deland D., Nakhre A., Oosterwijk E., Gulec S., Graham M.C., Larson S.M., Old L.J.: Phase I/II radioimmunotherapy trial with iodine-131 labeled monoclonal antibody (mAb) G250 in metastatic renal carcinoma. Clin Cancer Res 1998;4:2729-2739 .

Prewett M, Rothman M, Waksal H, Feldman M, Bander N.H., and Hicklin D.J.: Mouse-human chimeric anti-epidermal growth factor receptor antibody C225 inhibits the growth of human renal cell carcinoma xenografts in nude mice. Clin Cancer Res 1998;4:2957-2966.

Ebert T, Anastasiadis A, Bander NH: Renal Cell Cancer in Human Cell Culture (JR.W. Masters and B. Palsson eds.). Kluwer Academic Publishers 1999;1:231-249.

Uzzo RG, Rayman P, Kolenko V, Clark PE, Bloom T, Ward AM, Molto L, Tannenbaum C, Worford LJ, Bukowski R, Tubbs R, Hsi ED, Bander, NH, Novick AC, and Finke JH: Mechanisms of apoptosis in T cells from patients with renal cell carcinoma. Clin Cancer Res 1999;5:1219-1229.

Kolenko V, Uzzo RG, Bukowski R, Bander NH, Novick AC, Finke JH: Dead or dying: Necrosis vs. apoptosis in caspase deficient human renal cell carcinoma. Cancer Res, 1999,59:2838-2842.

Rajasekaran SA, Ball WJ Jr, Bander NH., Liu H, Pardee JD, and Rajasekaren AK: Reduced expression of b-subunit of Na,K-ATPase in human clear-cell renal cell carcinoma. J Urology, 1999;162:574-580.

Shirakawa T, Gardner TA, Ko S-C, Bander N, Woo S, Gotoh A, Kamidono S, Chung LWK and Kao C: Cytotoxocity of adenoviral-mediated cytosine deaminase plus 5-fluorocytosine gene therapy is superior to thymidine kinase plus acyclovir in a human renal cell carcinoma model. J Urology 1999; 162:949-954.

Scanlan MJ, Gordan JD, Williamson B, Stockert E, Bander NH, Jongeneel V, Gure AO, Jager D, Jager E, Knuth A, Chen YT and Old LJ: Antigens recognized by autologous antibody in patients with renal-cell carcinoma. Int J Cancer 1999, 83(4):456-464.

Oosterwijk E, Divgi CR, Steffens MS and Bander NH: Monoclonal antibodies in advanced renal cell carcinoma. Bukowski RM and Novick AC (eds). Renal Cell Carcinoma - Molecular Biology, Immunology, and Clinical Management, Humana Press 2000 ;22:343-358.

McKiernan JM, Buttyan R, Bander NH, de la Taille A, Stifelman MD, Emanuel ER, Bagiella E, Rubin MA, Katz AE, Olsson CA, Sawczuk IS: The detection of renal cancer cells in the peripheral blood via an enhanced RT-PCR assay for MN/CA9. Cancer, in press 2000.

Bander NH: Monoclonal antibodies in the diagnosis and treatment of renal cancer. Vogelzang NJ et al (eds). Comprehensive Textbook of Genitourinary Oncology, Second Edition, Lippincott Williams & Wilkins, in press 1999.